Ex abundanti cautela: From the tragedy of inadvertent sarcoma morcellation to inappropriate myoma screening
© The Author(s) 2016
Published: 6 February 2016
The recent commotion about the risk of unexpected malignancy during myoma morcellation may have divergent consequences. Some are positive for future women’s health care, while others may be negative. On the positive side, the ‘sarcoma awareness’ will lead to improvements in the diagnosis of myometrial lesions including leiomyosarcoma and in the technical aspects of safer, ‘spill-free’ myoma removal. On the negative side, the fear of an unexpected sarcoma may lead to unnecessary, more invasive surgery and avoidance of minimal invasive surgery—out of an abundance of caution.
I acknowledge that this simulation based on a few selected publications is simplistic and that the figures are prone to bias. However, I mean it to illustrate the real danger of generalizing partial knowledge in medicine.
The risk of fibroid morcellation is an important women’s health issue and cannot be underestimated. However, it should be put in the right perspective as done by Brölmann et al. . Both blunt denial of the problem and overreaction may have deleterious consequences.
The incidental diagnosis of a fibroid in an asymptomatic woman is rarely an indication for surgery.
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
- Van den Bosch T, Dueholm M, Leone FP, Valentin L, Rasmussen CK, Votino A, Van Schoubroeck D, Landolfo C, Installé AJ, Guerriero S, Exacoustos C, Gordts S, Benacerraf B, D'Hooghe T, De Moor B, Brölmann H, Goldstein S, Epstein E, Bourne T, Timmerman D (2015) Terms and definitions for describing myometrial pathology using ultrasonography. Ultrasound Obstet Gynecol. doi:10.1002/uog.14806 Google Scholar
- Divakar H. (2008) Asymptomatic uterine fibroids. Best Pract Res Clin Obstet Gynaecol 22(4):643–654Google Scholar
- Hacker NF (2000) Uterine cancer. In: Berek JS, Hacker NF (eds) Practical gynecologic oncology, Third edn. Lippincott Williams & Wilkins, Philadelphia, pp. 407–456Google Scholar
- Amant F, Coosemans A, Debiec-Rychter M, Timmerman D, Vergote I (2009) Clinical management of uterine sarcomas. Lancet Oncol 10(12):1188–1198View ArticlePubMedGoogle Scholar
- Varol N, Healey M, Tang P, Sheehan P, Maher P, Hill D (2001) Ten-year review of hysterectomy morbidity and mortality: can we change direction? Aust N Z J Obstet Gynaecol 41(3):295–302View ArticlePubMedGoogle Scholar
- Brölmann H, Tanos V, Grimbizis G, Ind T, Philips K, van den Bosch T, Sawalhe S, van den Haak L, Jansen FW, Pijnenborg J, Taran FA, Brucker S, Wattiez A, Campo R, O'Donovan P, de Wilde RL; European Society of Gynaecological Endoscopy (ESGE) steering committee on fibroid morcellation (2015) Options on fibroid morcellation: a literature review. Gynecol Surg 12(1):3–15View ArticleGoogle Scholar